Arcutis Biotherapeutics, Inc. (ARQT) vs Tarsus Pharmaceuticals, Inc. (TARS)

• Arcutis Biotherapeutics, Inc. ARQT 25.55 ▼ −5.37%
• Tarsus Pharmaceuticals, Inc. TARS 68.81 ▲ +1.91%

Arcutis Biotherapeutics, Inc. and Tarsus Pharmaceuticals, Inc. are both Biotechnology companies. Arcutis Biotherapeutics, Inc. and Tarsus Pharmaceuticals, Inc. are of similar size ($3.4B and $3.3B). Tarsus Pharmaceuticals, Inc. has negative trailing earnings, so its P/E is not meaningful; Arcutis Biotherapeutics, Inc. trades at 112×. Tarsus Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 86.3% against 60.0%. Arcutis Biotherapeutics, Inc. has the higher net margin (5.88% vs −102.9%) and the higher return on invested capital (23.5% vs 0.00%). Across the 18 metrics below, Arcutis Biotherapeutics, Inc. leads on 13 and Tarsus Pharmaceuticals, Inc. on 5.